AP366A - Novel Steroids. - Google Patents

Novel Steroids. Download PDF

Info

Publication number
AP366A
AP366A APAP/P/1992/000353A AP9200353A AP366A AP 366 A AP366 A AP 366A AP 9200353 A AP9200353 A AP 9200353A AP 366 A AP366 A AP 366A
Authority
AP
ARIPO
Prior art keywords
compound
formula
ene
dione
steroid
Prior art date
Application number
APAP/P/1992/000353A
Other languages
English (en)
Other versions
AP9200353A0 (en
Inventor
Paul Hakan Andersson
Bengt Ingemar Axelsson
Ralph Lennart Brattsand
Bror Arne Thalen
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab Astra filed Critical Ab Astra
Publication of AP9200353A0 publication Critical patent/AP9200353A0/xx
Application granted granted Critical
Publication of AP366A publication Critical patent/AP366A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
APAP/P/1992/000353A 1991-02-04 1992-01-27 Novel Steroids. AP366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9100341A SE9100341D0 (sv) 1991-02-04 1991-02-04 Novel steroids

Publications (2)

Publication Number Publication Date
AP9200353A0 AP9200353A0 (en) 1992-01-31
AP366A true AP366A (en) 1994-10-21

Family

ID=20381806

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000353A AP366A (en) 1991-02-04 1992-01-27 Novel Steroids.

Country Status (40)

Country Link
US (2) US5674861A (ro)
EP (1) EP0570454B1 (ro)
JP (1) JPH06505232A (ro)
KR (1) KR100216720B1 (ro)
CN (3) CN1034868C (ro)
AP (1) AP366A (ro)
AT (1) ATE178611T1 (ro)
BG (1) BG62211B1 (ro)
CA (1) CA2103924A1 (ro)
CZ (1) CZ281685B6 (ro)
DE (1) DE69228870T2 (ro)
DK (1) DK0570454T3 (ro)
DZ (1) DZ1553A1 (ro)
EE (1) EE03111B1 (ro)
ES (1) ES2133315T3 (ro)
FI (1) FI933450A (ro)
GR (1) GR3030657T3 (ro)
HK (1) HK1010733A1 (ro)
HU (1) HU218275B (ro)
IE (1) IE920166A1 (ro)
IL (1) IL100532A (ro)
IS (1) IS1601B (ro)
MA (1) MA22406A1 (ro)
MX (1) MX9200324A (ro)
NO (1) NO304073B1 (ro)
NZ (1) NZ241210A (ro)
PH (1) PH31284A (ro)
PL (1) PL170000B1 (ro)
PT (1) PT100086B (ro)
RO (1) RO111195B1 (ro)
RU (1) RU2111212C1 (ro)
SE (1) SE9100341D0 (ro)
SG (1) SG52557A1 (ro)
SI (1) SI9210065B (ro)
SK (1) SK281801B6 (ro)
TN (1) TNSN92007A1 (ro)
UA (1) UA41267C2 (ro)
WO (1) WO1992013872A1 (ro)
YU (1) YU48892B (ro)
ZA (1) ZA92233B (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
KR960700266A (ko) * 1993-01-08 1996-01-19 클래스 빌헬름슨 신규 결장- 또는 회장-특이성 스테로이드 유도체(Novel Colon-or lleum-Specific Steroid Derivatives)
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
GB9423919D0 (en) * 1994-11-26 1995-01-11 Rhone Poulenc Rorer Ltd Chemical process
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
IT1291288B1 (it) * 1997-04-30 1999-01-07 Farmabios Srl Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
GB0110411D0 (en) * 2001-04-27 2001-06-20 Astrazeneca Ab Chemical process
EP1465915A1 (en) * 2001-09-25 2004-10-13 PHARMACIA & UPJOHN COMPANY Stereoselective transacetalization of steroidal c-22 acetonide
NZ537717A (en) 2002-07-08 2006-04-28 Pliva Istrazivacki Inst D New compounds, compositions and methods for treatment of inflammatory diseases and conditions
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
WO2004017904A2 (en) * 2002-08-23 2004-03-04 The Mclean Hospital Corporation Corticosteroid conjugates and uses thereof
TW200417371A (en) * 2003-02-21 2004-09-16 Upjohn Co A continuous process for the production of R-rofleponide
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
ATE453658T1 (de) 2004-10-27 2010-01-15 Glaxosmithkline Zagreb Konjugate mit entzündungshemmender aktivität
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US20080207577A1 (en) * 2005-07-11 2008-08-28 Astrazeneca Ab Combination I
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928326A (en) * 1972-05-19 1975-12-23 Bofors Ab Process for the separation of stereoisomeric mixtures into their components and components obtained hereby
EP0054010A1 (en) * 1980-12-04 1982-06-16 Aktiebolaget Draco 4-Pregnene-derivatives, a process for their preparation and composition for the treatment of inflammatory conditions
EP0262108A1 (en) * 1986-09-25 1988-03-30 Astra Pharmaceutical Production AB A method of controlling the empimeric distribution in the preparation of 16,17-acetals or ketals of pregnane derivatives

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3357974A (en) * 1965-12-28 1967-12-12 Merck & Co Inc Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
SE378109B (ro) * 1972-05-19 1975-08-18 Bofors Ab
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
CN1060471A (zh) * 1985-04-04 1992-04-22 得拉科公司 新的16，17-缩醛取代雄甾烷-17β-酮类的制备方法
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
HU203562B (en) * 1989-03-09 1991-08-28 Richter Gedeon Vegyeszet Process for producing new steroide diols and pharmaceutical compositions containing them
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928326A (en) * 1972-05-19 1975-12-23 Bofors Ab Process for the separation of stereoisomeric mixtures into their components and components obtained hereby
EP0054010A1 (en) * 1980-12-04 1982-06-16 Aktiebolaget Draco 4-Pregnene-derivatives, a process for their preparation and composition for the treatment of inflammatory conditions
EP0262108A1 (en) * 1986-09-25 1988-03-30 Astra Pharmaceutical Production AB A method of controlling the empimeric distribution in the preparation of 16,17-acetals or ketals of pregnane derivatives

Also Published As

Publication number Publication date
NO932761D0 (no) 1993-08-02
AP9200353A0 (en) 1992-01-31
UA41267C2 (uk) 2001-09-17
WO1992013872A1 (en) 1992-08-20
SE9100341D0 (sv) 1991-02-04
PT100086A (pt) 1994-05-31
FI933450A0 (fi) 1993-08-03
KR100216720B1 (ko) 1999-10-01
YU48892B (sh) 2002-10-18
DE69228870D1 (de) 1999-05-12
HK1010733A1 (en) 1999-06-25
BG97971A (bg) 1994-04-29
CN1058724C (zh) 2000-11-22
PL170000B1 (pl) 1996-10-31
DE69228870T2 (de) 1999-08-19
NO932761L (no) 1993-08-02
SI9210065B (en) 2001-12-31
EP0570454A1 (en) 1993-11-24
MA22406A1 (fr) 1992-10-01
SG52557A1 (en) 1998-09-28
IS3808A (is) 1992-08-05
ES2133315T3 (es) 1999-09-16
TNSN92007A1 (fr) 1993-06-08
ZA92233B (en) 1992-10-28
EP0570454B1 (en) 1999-04-07
FI933450A (fi) 1993-08-03
GR3030657T3 (en) 1999-10-29
NO304073B1 (no) 1998-10-19
CZ281685B6 (cs) 1996-12-11
CN1140059A (zh) 1997-01-15
PH31284A (en) 1998-07-06
EE03111B1 (et) 1998-08-17
CA2103924A1 (en) 1992-08-05
IL100532A (en) 1996-05-14
HU9302244D0 (en) 1993-10-28
MX9200324A (es) 1992-09-01
IE920166A1 (en) 1992-08-12
CZ149693A3 (en) 1994-03-16
BG62211B1 (bg) 1999-05-31
YU6592A (sh) 1995-01-31
IS1601B (is) 1996-10-18
CN1034868C (zh) 1997-05-14
SI9210065A (en) 1995-02-28
HUT64973A (en) 1994-03-28
CN1064079A (zh) 1992-09-02
RO111195B1 (ro) 1996-07-30
NZ241210A (en) 1993-08-26
HU218275B (en) 2000-07-28
US5939409A (en) 1999-08-17
CN1140178A (zh) 1997-01-15
CN1052155C (zh) 2000-05-10
PT100086B (pt) 1999-06-30
DK0570454T3 (da) 1999-10-18
SK281801B6 (sk) 2001-08-06
US5674861A (en) 1997-10-07
SK79693A3 (en) 1994-03-09
DZ1553A1 (fr) 2002-02-17
ATE178611T1 (de) 1999-04-15
JPH06505232A (ja) 1994-06-16
RU2111212C1 (ru) 1998-05-20
AU1230792A (en) 1992-09-07
AU661471B2 (en) 1995-07-27
IL100532A0 (en) 1992-09-06

Similar Documents

Publication Publication Date Title
AP366A (en) Novel Steroids.
KR100205835B1 (ko) 신규 스테로이드 에스테르
US5888995A (en) Steroid esters
JPH0533714B2 (ro)
AU661471C (en) Novel steroids
JPH0780900B2 (ja) １６，１７−アセタ−ル置換プレグナン２１−オイツク酸誘導体およびその製法
AU661472C (en) Novel steroid esters
SI9210064A (sl) Nove antiinflamatorno in antialergijsko aktivne spojine, glukokortikosteroidi ter postopki za njihovo pripravo